JPH032550B2 - - Google Patents

Info

Publication number
JPH032550B2
JPH032550B2 JP56078314A JP7831481A JPH032550B2 JP H032550 B2 JPH032550 B2 JP H032550B2 JP 56078314 A JP56078314 A JP 56078314A JP 7831481 A JP7831481 A JP 7831481A JP H032550 B2 JPH032550 B2 JP H032550B2
Authority
JP
Japan
Prior art keywords
blood
adsorbent
chitin
adsorption
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56078314A
Other languages
Japanese (ja)
Other versions
JPS57192563A (en
Inventor
Takashi Komai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON KOTAI KENKYUSHO KK
Original Assignee
NIPPON KOTAI KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON KOTAI KENKYUSHO KK filed Critical NIPPON KOTAI KENKYUSHO KK
Priority to JP56078314A priority Critical patent/JPS57192563A/en
Publication of JPS57192563A publication Critical patent/JPS57192563A/en
Publication of JPH032550B2 publication Critical patent/JPH032550B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、吸着剤層を、アシルキチン膜にて被
覆した吸着剤粒子群により形成してなる吸着型血
液浄化器に関するものであり、その主な目的は、
吸着剤層と血液適合性及び吸着性能を改善するこ
とである。 従来、腎不全及び肝不全の治療法として、血液
透析法により、血液中の有害・不要物質を除去す
る方法が実施されていた。しかし、従来の血液透
析法においては、透析装置が大きいこと、透析時
間が長いこと、多量の透析液を要すること、中分
子量の有害・不要物質を除去し難いこと等の問題
を有していた。 従来の血液透析法の問題点を解決する方法とし
て、活性炭素、多孔性吸着樹脂の如き吸着剤を用
いて血液の直接潅流により血液中の有害・不要物
質を吸着・除去する方法が知られていたが、これ
らの吸着剤は、血液と直接接触することにより、
吸着剤表面にて血液の吸着・凝固が起ること、吸
着剤微粉が血液中に混入して生体内にて反応を起
すこと等の問題を有していた。此等の問題点を解
決するために、吸着剤表面をニトロセルロース
膜、酢酸セルロース膜、ゼラチン膜、ポリヒドロ
キシエチルメタクリレート膜の如き高分子膜によ
り被覆する方法が知られていたが、血液との接触
により吸着剤表面にて血液の吸着・凝固の恐れが
あること、吸着剤の吸着性能が低下すること、高
分子膜成分が血液中に溶出する恐れがあること、
高圧蒸気滅菌において活性炭素表面の高分子膜が
軟化・変形を起す恐れがあること等の問題を有し
ていた。 本発明者は、如上の問題点を改善すべく種々検
討した結果、吸着型血液浄化器の吸着剤層とし
て、アシルキチン膜にて被覆した吸着剤粒子群を
使用することにより、吸着剤層の血液適合性及び
吸着性能が改善できることを見出し、本発明の吸
着型血液浄化器を完成したのである。 次に、本発明の構成について詳述する。 本発明は、図面に示す如く、吸着剤層2を、ア
シルキチン膜にて被覆した吸着剤粒子群により形
成することを特徴とする、吸着型血液浄化器1で
ある。 図面は、本発明の吸着型血液浄化器に係わる実
施例の一部断面の正面図である。図面中、1は吸
着型血液浄化器、2吸着剤層、3は過格子、4
は整流室、5は潅流液入口、6は潅流液出口であ
る。 本発明の吸着型血液浄化器を用いた血液浄化方
法を図面により説明すれば、即ち、潅流液(血液
または血漿液)は、潅流液入口5より血液浄化
器1内に導入され、整流室4に充満され、次いで
過格子3を通過して、吸着剤層2に流布されて
潅流液中の有害・不要物質が吸着・除去される。
次に、浄化された潅流液は、反対側の過格子を
通過して整流室に充満され、潅流液出口6より導
出されて、潅流液が血液の場合には静脈を通じて
生体内に還流され、また潅流液が液の場合には
過により浄化された血液と合流させて静脈を通
じて生体内に還流される。 本発明において吸着剤層を形成する吸着剤粒子
は、活性炭素粒子、多孔性吸着樹脂(例えば、ス
チレン−ジビニルベンゼン共重合樹脂、ポリアク
リル酸エステル樹脂など)粒子、イオン交換樹脂
粒子等であり、粒径0.1〜2mmの球状体が好適で
ある。 本発明に用いられるアシルキチンとしては、フ
オルミルキチン、アセチルキチン、プロピチニル
キチン、ブチリルキチン、カプロイルキチン、カ
プリルキチン、ラウロイルキチン、ベンゾイルキ
チン等を挙げることができ、それらの溶液から皮
膜形成が可能であること、形成されたアシルキチ
ン膜により吸着剤の砕片あるいは微粉の血液中へ
の混入を防止できること、アシルキチン自体が生
体に対して本質的に無反応性であり、且つ血液に
対して抗凝固性であるので、アシルキチン膜表面
にて血液と直接接触しても血液の凝固を起さない
こと等の特徴を有する。また、本発明に用いられ
るアシルキチン膜は、耐水性及び耐熱性を有する
ので、血液中への溶出及び吸着剤同志の集合を起
すことがなく、また高圧蒸気滅菌において軟化・
変形を起すことがない。 本発明において、吸着剤をアシルキチン膜にて
被覆する方法としては、 コーテイングパンを用いて、吸着剤粒子を転
動させ乍ら、吸着剤粒子にアシルキチン溶液を
スプレーコーテイングし、転動混合し乍ら熱風
により溶剤を一部除去して、次いで非溶媒中に
分散させて残留した溶剤を溶脱させて、吸着剤
粒子をアシルキチン膜にて被覆する方法、 吸着剤粒子をアシルキチン溶液中に浸漬・混
合し、次に過または遠心脱液した後に熱風に
より溶剤の一部を揮発させ、次いで非溶媒中に
分散させて溶剤を溶脱させて、吸着剤粒子をア
シルキチン膜にて被覆する方法等がある。これ
らの被覆方法により形成されたアシルキチン膜
は網状構造であり、吸着剤粒子の吸着性能を低
下させることがなく、しかも吸着剤表面にて血
液の吸着・凝固を防ぐ効果を有する。 本発明における吸着剤層の形成方法としては、
図面に示す如く、アシルキチン膜にて被覆した吸
着剤粒子を容器本体内の2個の過格子間に充填
して形成する方法等が挙げられ、而して吸着剤層
において潅流液を圧力損失少なく且つ均一の分布
状態にて流通させることができる。尚、本発明の
吸着剤粒子の使用量は、使用目的、使用形態、用
法等により異なるが、50〜500gが適当である。 本発明の吸着型血液浄化器は、血液直接潅流
法、血液過法等に適用することができる。即
ち、血液直接潅流法を説明すれば、生体の動脈側
より流出された血液を、血液回路経由で血液浄化
器に導入し、血液浄化器内の吸着剤層に直接潅流
して血液中の有害・不要物質を吸着・除去し、次
いで、浄化された血液を生体内の静脈側に潅流す
る方法である。また、血液過法を説明すれば、
生体の動脈側より流出された血液を、血液回路経
由にて血液過器に導入し、血液過器内の過
膜により血液中の有害・不要物質含有の血漿成分
を過し、液を回収路経由で血液浄化器に導入
し、血液浄化器内の吸着剤層に潅流して液中の
有害・不要物質を吸着・除去し、次いで浄化され
た液を浄化液導出経由で血液回路と合流して
過済みの血液とともに生体内の静脈側に還流す
る。他方、過剰の液を液排泄路経由で体外へ
排出する。 次に、本発明の吸着型血液浄化器による効果を
列挙する。 (イ) 本発明の吸着型血液浄化器は、血液直接潅流
法、血液液法等による人工腎臓または人工肝
臓として適用することができる。 (ロ) 本発明に用いられるアシルキチン膜は、高圧
蒸気滅菌において軟化・変形・分解を起すこと
なく、而して潅流液(血液または液)を汚染
することがない。 (ハ) 本発明に用いられる吸着剤層は、血液を吸
着・凝固させることなく流通でき、血液中の有
害・不要物質を効率良く吸着・除去することが
できる。 次に、本発明を実施例により説明する。 実施例 1 粒径0.3〜0.6mmの球状多孔性吸着樹脂(スチレ
ン−ジビニルベンゼン共重合樹脂)粒子150gを、
アセチル化度2.0のアセチルキチン1%蟻酸溶液
中に浸漬・混合し、次に、過剰のアセチルキチン
溶液を過により脱液した後、熱風により蟻酸の
一部を揮発させ、次いで吸着樹脂粒子を脱イオン
水中に投入し・分散させて蟻酸を溶脱させ、過
した後、よく水洗して吸着樹脂粒子をアセチルキ
チン膜にて被覆させた。 アセチルキチン膜にて被覆させた吸着樹脂粒子
を、図に示す如く、ポリプロピレン樹脂製容器内
に充填して2個の過格子間に吸着剤層を形成し
た。次いで、容器内に生理食塩水を充填し、容器
内の気泡を除去して出入口に密栓した。次に、高
圧蒸気滅菌処理(121℃、30分)を行なつて吸着
型血液浄化器を得た。 得られた血液浄化器を用いて、血液回路、血液
ポンプ、圧力計等を連結して人工臓器装置を組立
てた。次に、ペントバルビタール200mg/dlリン
酸緩衝溶液(PH7.4)10を用いて、直接潅流法
(37℃にて200ml/分潅法)により吸着能のin−
vitro実験を行なつた。比較のために、セルロー
スアセテート膜にて被覆させた吸着樹脂粒子及び
原料吸着樹脂粒子各々を用いて同様の構成の血液
浄化器を作成し、同様に吸着能のin−vitro実験
を行なつた。吸着能の比較実験結果は、表−1に
示す通り、アセチルキチン膜被覆の吸着樹脂粒子
を用いた血液浄化器の吸着能は、原料吸着樹脂粒
子を用いた血液浄化器の吸着能と同位でありセル
ロースアセテート膜被覆の吸着樹脂粒子を用いた
血液浄化器の吸着能よりも優位であつた。表−1
は、ペントバルビタールの吸着能(百分率による
吸着量)の比較表である。
The present invention relates to an adsorption type blood purifier in which an adsorbent layer is formed of a group of adsorbent particles coated with an acyl chitin film, and its main purpose is to
The aim is to improve the adsorbent layer and blood compatibility and adsorption performance. Conventionally, as a treatment for renal failure and liver failure, hemodialysis has been used to remove harmful and unnecessary substances from the blood. However, conventional hemodialysis methods have problems such as large dialysis machines, long dialysis times, large amounts of dialysate, and difficulty in removing medium-molecular-weight harmful and unnecessary substances. . As a method to solve the problems of conventional hemodialysis methods, there is a known method of adsorbing and removing harmful and unnecessary substances from the blood through direct perfusion of blood using adsorbents such as activated carbon and porous adsorbent resins. However, these adsorbents, by direct contact with blood,
There have been problems such as adsorption and coagulation of blood on the surface of the adsorbent, and fine powder of the adsorbent mixed into the blood and causing a reaction in the living body. In order to solve these problems, methods have been known in which the surface of the adsorbent is coated with a polymer film such as a nitrocellulose film, a cellulose acetate film, a gelatin film, or a polyhydroxyethyl methacrylate film. There is a risk that blood may be adsorbed and coagulated on the surface of the adsorbent due to contact, the adsorption performance of the adsorbent may be reduced, and the polymer membrane components may be eluted into the blood.
During high-pressure steam sterilization, the polymer film on the surface of the activated carbon may soften or deform. As a result of various studies to improve the above-mentioned problems, the inventors of the present invention have discovered that the blood in the adsorbent layer can be improved by using a group of adsorbent particles coated with an acyl chitin film as the adsorbent layer of an adsorption type blood purifier. They discovered that the compatibility and adsorption performance could be improved, and completed the adsorption type blood purifier of the present invention. Next, the configuration of the present invention will be explained in detail. As shown in the drawings, the present invention is an adsorption type blood purifier 1 characterized in that an adsorbent layer 2 is formed of an adsorbent particle group coated with an acyl chitin film. The drawing is a partially sectional front view of an embodiment of the adsorption type blood purifier of the present invention. In the drawing, 1 is an adsorption type blood purifier, 2 is an adsorbent layer, 3 is a superlattice, and 4 is a superlattice.
is a rectification chamber, 5 is a perfusate inlet, and 6 is a perfusate outlet. The blood purification method using the adsorption type blood purifier of the present invention will be explained with reference to the drawings. In other words, perfusate (blood or plasma) is introduced into the blood purifier 1 from the perfusate inlet 5, and the rectifying chamber 4 It then passes through the superlattice 3 and is distributed on the adsorbent layer 2, where harmful and unnecessary substances in the perfusate are adsorbed and removed.
Next, the purified perfusate passes through the overgrid on the opposite side, fills the rectification chamber, is led out from the perfusate outlet 6, and, if the perfusate is blood, is returned to the living body through the veins. If the perfusate is a liquid, it is combined with blood purified by filtration and returned to the body through the veins. In the present invention, the adsorbent particles forming the adsorbent layer are activated carbon particles, porous adsorption resin particles (for example, styrene-divinylbenzene copolymer resin, polyacrylic acid ester resin, etc.) particles, ion exchange resin particles, etc. Spherical bodies with a particle size of 0.1 to 2 mm are preferred. Examples of the acyl chitin used in the present invention include formalyl chitin, acetyl chitin, propitinyl chitin, butyryl chitin, caproyl chitin, caprylic chitin, lauroyl chitin, benzoyl chitin, etc., and it is possible to form a film from a solution thereof; The formed acyl chitin film can prevent adsorbent fragments or fine particles from entering the blood, and the acyl chitin itself is essentially non-reactive to living organisms and anticoagulant to blood. It has characteristics such as not causing blood coagulation even if it comes into direct contact with blood on the surface of the acyl chitin film. In addition, the acyl chitin film used in the present invention has water resistance and heat resistance, so it does not elute into blood or aggregate with adsorbents, and does not soften or soften during high-pressure steam sterilization.
No deformation occurs. In the present invention, the method of coating the adsorbent with an acyl chitin film includes spray coating the adsorbent particles with an acyl chitin solution while rolling the adsorbent particles using a coating pan, and mixing by rolling. A method of partially removing the solvent with hot air, then dispersing it in a non-solvent to leach the remaining solvent, and coating the adsorbent particles with an acyl chitin film. A method in which the adsorbent particles are immersed and mixed in an acyl chitin solution. Next, there is a method in which the adsorbent particles are coated with an acyl chitin film by evaporating a part of the solvent with hot air after evaporation or centrifugation, and then dispersing the adsorbent in a non-solvent to leached the solvent. The acyl chitin film formed by these coating methods has a network structure, does not reduce the adsorption performance of adsorbent particles, and has the effect of preventing adsorption and coagulation of blood on the adsorbent surface. The method for forming the adsorbent layer in the present invention is as follows:
As shown in the drawing, there is a method in which adsorbent particles coated with an acyl chitin film are filled between two superlattices in the container body, thereby reducing the pressure loss of the perfusion fluid in the adsorbent layer. Moreover, it can be distributed in a uniform distribution state. The amount of adsorbent particles used in the present invention varies depending on the purpose of use, form of use, method of use, etc., but is suitably 50 to 500 g. The adsorption type blood purifier of the present invention can be applied to direct blood perfusion methods, blood perfusion methods, and the like. In other words, in the direct blood perfusion method, blood flowing out from the artery side of a living body is introduced into a blood purifier via a blood circuit, and then directly perfused into an adsorbent layer in the blood purifier to eliminate harmful substances in the blood.・This is a method in which unnecessary substances are adsorbed and removed, and then the purified blood is perfused into the veins of the body. Also, if you explain the blood flow method,
Blood flowing out from the arterial side of the living body is introduced into the blood filter via the blood circuit, plasma components containing harmful and unnecessary substances in the blood are passed through the membrane in the blood filter, and the liquid is passed through the recovery channel. The purified liquid is introduced into the blood purifier via the blood purifier, perfused into the adsorbent layer in the blood purifier to adsorb and remove harmful and unnecessary substances in the liquid, and then the purified liquid is merged with the blood circuit via the purified liquid outlet. The blood flows back into the veins of the body together with the filtered blood. On the other hand, excess fluid is excreted out of the body via fluid excretory channels. Next, the effects of the adsorption type blood purifier of the present invention will be listed. (a) The adsorption type blood purifier of the present invention can be applied as an artificial kidney or artificial liver using a direct blood perfusion method, a blood fluid method, or the like. (b) The acyl chitin membrane used in the present invention does not soften, deform, or decompose during high-pressure steam sterilization, and does not contaminate perfusate (blood or fluid). (c) The adsorbent layer used in the present invention can circulate blood without adsorbing or coagulating blood, and can efficiently adsorb and remove harmful and unnecessary substances in blood. Next, the present invention will be explained by examples. Example 1 150 g of spherical porous adsorption resin (styrene-divinylbenzene copolymer resin) particles with a particle size of 0.3 to 0.6 mm were
Acetyl chitin was immersed and mixed in a 1% formic acid solution with a degree of acetylation of 2.0, and then the excess acetyl chitin solution was removed by filtration, a portion of the formic acid was evaporated with hot air, and the adsorbed resin particles were removed. The formic acid was eluted by dispersing it in ionized water, filtered, and thoroughly washed with water to coat the adsorbed resin particles with an acetyl chitin film. Adsorbent resin particles coated with an acetyl chitin film were filled into a polypropylene resin container as shown in the figure to form an adsorbent layer between two superlattices. Next, the container was filled with physiological saline, air bubbles in the container were removed, and the entrance and exit port were tightly plugged. Next, high-pressure steam sterilization treatment (121°C, 30 minutes) was performed to obtain an adsorption type blood purifier. Using the obtained blood purifier, an artificial organ device was assembled by connecting a blood circuit, a blood pump, a pressure gauge, etc. Next, using 200 mg/dl pentobarbital phosphate buffer solution (PH7.4) 10, the adsorption capacity was determined by direct perfusion method (200 ml/min perfusion method at 37°C).
Performed in vitro experiments. For comparison, a blood purifier with a similar configuration was prepared using adsorbent resin particles coated with a cellulose acetate membrane and raw adsorbent resin particles, and an in-vitro experiment of adsorption capacity was similarly conducted. As shown in Table 1, the adsorption capacity comparison experiment results show that the adsorption capacity of a blood purifier using adsorption resin particles coated with acetyl chitin membrane is on the same level as that of a blood purification device using raw material adsorption resin particles. The adsorption capacity was superior to that of a blood purifier using adsorption resin particles coated with cellulose acetate membrane. Table-1
is a comparison table of pentobarbital adsorption capacity (adsorption amount in percentage).

【表】 また、3種類の血液浄化器を用いて前記と同様
に人工臓器装置を組立て、次に、雑種肝障害犬を
用いて、血液直接潅流法(37℃にて2時間潅流)
によりin−vivo実験を行なつた。それらの実験結
果は、表−2に示す通り、アセチルキチン被覆の
吸着樹脂粒子を用いた血液浄化器の血液成分変化
は、セルロースアセテート膜被覆の吸着樹脂粒子
及び原料吸着樹脂粒子を用いた血液浄化器の血液
成分変化よりも少なく、アセチルキチン被覆の吸
着樹脂粒子の血液適合性は優位であつた。表−2
は、2時間血液直接潅流による白血球数及び血小
板数の減少率(%)をあらわす比較表である。
[Table] In addition, an artificial organ device was assembled in the same manner as above using three types of blood purifiers, and then a direct blood perfusion method (perfusion for 2 hours at 37°C) was performed using a mongrel liver-impaired dog.
In-vivo experiments were carried out. As shown in Table 2, the experimental results show that blood composition changes in the blood purifier using acetylchitin-coated adsorbent resin particles are different from blood purification using cellulose acetate membrane-coated adsorbent resin particles and raw material adsorbent resin particles. The blood compatibility of the adsorbent resin particles coated with acetyl chitin was superior to that of the blood component change in the blood vessel. Table-2
This is a comparison table showing the reduction rate (%) of white blood cell count and platelet count due to direct blood perfusion for 2 hours.

【表】 実施例 2 粒径0.6〜0.8mmの球状活性炭素粒子150gをア
セチル化度2.0のアセチルキチン1%蟻酸溶液に
より、実施例1と同様にして、アセチルキチン膜
にて被覆させた。 アセチルキチン膜にて被覆させた活性炭素粒子
を、図に示す如く、ポリカーボネート樹脂製容器
内に充填して2個の過格子間に吸着剤層を形成
した。次いで、容器内に生理食塩水を充填し、容
器内の気泡を除去して出入口に密栓した。次に、
高圧蒸気滅菌処理(121℃、30分)を行なつて吸
着型血液浄化器を得た。 得られた血液浄化器を用いて、血液回路、血液
ポンプ、圧力計等を連結して人工臓器装置を組立
て、血液直接潅流法により血液浄化実験を行なつ
た。その結果、血液中の有害・不要物質を効率良
く且つ選択的に吸着・除去すること及び活性炭素
粒子表面での血液成分の吸着・凝固を防止するこ
とができ、要するに効率良い血液浄化が可能であ
つた。
[Table] Example 2 150 g of spherical activated carbon particles having a particle size of 0.6 to 0.8 mm were coated with an acetyl chitin film in the same manner as in Example 1 using a 1% formic acid solution of acetyl chitin with a degree of acetylation of 2.0. Activated carbon particles coated with an acetyl chitin film were filled into a polycarbonate resin container to form an adsorbent layer between two superlattices, as shown in the figure. Next, the container was filled with physiological saline, air bubbles in the container were removed, and the entrance and exit port were tightly plugged. next,
An adsorption type blood purifier was obtained by high-pressure steam sterilization (121°C, 30 minutes). Using the obtained blood purifier, an artificial organ device was assembled by connecting a blood circuit, a blood pump, a pressure gauge, etc., and a blood purification experiment was conducted using the direct blood perfusion method. As a result, harmful and unnecessary substances in the blood can be efficiently and selectively adsorbed and removed, and adsorption and coagulation of blood components on the surface of activated carbon particles can be prevented.In short, efficient blood purification is possible. It was hot.

【図面の簡単な説明】[Brief explanation of the drawing]

図面は、本発明の吸着型血液浄化器に係わる実
施例の一部断面の正面図である。 図面中、1は吸着型血液浄化器、2は吸着剤
層、3は過格子、4は整流器、5は潅流液入
口、6は潅流液出口である。
The drawing is a partially sectional front view of an embodiment of the adsorption type blood purifier of the present invention. In the drawing, 1 is an adsorption type blood purifier, 2 is an adsorbent layer, 3 is a superlattice, 4 is a rectifier, 5 is a perfusate inlet, and 6 is a perfusate outlet.

Claims (1)

【特許請求の範囲】 1 吸着剤層を、アシルキチン膜にて被覆した吸
着剤粒子群により形成することを特徴とする、吸
着型血液浄化器。 2 アシルキチン膜が、フオルミルキチン、アセ
チルキチン、プロピオニルキチン、ブチリルキチ
ン、カプロイルキチン、カプリルキチン、ラウロ
イルキチンまたはベンゾイルキチンから成ること
を特徴とする、特許請求の範囲第1項記載の吸着
型血液浄化器。 3 アシルキチン膜が、網状構造であることを特
徴とする、特許請求の範囲第1項及び第2項記載
の吸着型血液浄化器。
[Scope of Claims] 1. An adsorption type blood purifier, characterized in that the adsorbent layer is formed of a group of adsorbent particles coated with an acyl chitin film. 2. The adsorption type blood purifier according to claim 1, wherein the acylchitin film is composed of fluoroylchitin, acetylchitin, propionylchitin, butyrylchitin, caproylchitin, caprylicchitin, lauroylchitin, or benzoylchitin. 3. The adsorption type blood purifier according to claims 1 and 2, wherein the acyl chitin membrane has a network structure.
JP56078314A 1981-05-22 1981-05-22 Adsorbing type blood purifying device Granted JPS57192563A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56078314A JPS57192563A (en) 1981-05-22 1981-05-22 Adsorbing type blood purifying device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56078314A JPS57192563A (en) 1981-05-22 1981-05-22 Adsorbing type blood purifying device

Publications (2)

Publication Number Publication Date
JPS57192563A JPS57192563A (en) 1982-11-26
JPH032550B2 true JPH032550B2 (en) 1991-01-16

Family

ID=13658472

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56078314A Granted JPS57192563A (en) 1981-05-22 1981-05-22 Adsorbing type blood purifying device

Country Status (1)

Country Link
JP (1) JPS57192563A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996011716A1 (en) * 1994-10-18 1996-04-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Blood component adsorption carrier and method of manufacturing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5222070A (en) * 1975-08-12 1977-02-19 Kuraray Co Polyvinyl chloride compound having improved interface between it and blood or reagent liquor
JPS54135495A (en) * 1978-04-13 1979-10-20 Asahi Chemical Ind Medical silicone resin
JPS54139294A (en) * 1978-04-20 1979-10-29 Mitsubishi Rayon Co Dialysing membrane having superior transmission property
JPS55161805A (en) * 1979-06-05 1980-12-16 Kureha Chem Ind Co Ltd Polyion complex
JPS55161804A (en) * 1979-06-05 1980-12-16 Kureha Chem Ind Co Ltd Polyion complex composed of chitin derivative

Also Published As

Publication number Publication date
JPS57192563A (en) 1982-11-26

Similar Documents

Publication Publication Date Title
US3725113A (en) Blood compatible microencapsulated detoxicants and method for making
EP2735326B1 (en) Liver support system
Reiter et al. In vitro removal of therapeutic drugs with a novel adsorbent system
JP3011463B2 (en) Therapeutic blood purification apparatus and method for producing transfusion for hemodiafiltration (HDF)
JPS5928972A (en) Adsorbing body for purifying blood and production thereof
JPS6171063A (en) Selective separation of high-molecular weight substance in blood
Winchester et al. Sorbent hemoperfusion in end-stage renal disease: an in-depth review
WO2003057306A1 (en) Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids
CN109689124B (en) Liver support system
JP2023502995A (en) Porous Membrane Containing Adsorbent Particles for Improved Urea Capture
JPH032550B2 (en)
de Francisco et al. Hemodiafiltration with on-line endogenous reinfusion
JPH0510104B2 (en)
JP2011019685A (en) Hemocatharsis column
EP2922585A1 (en) Adsorbent for dialysis
JP3192711B2 (en) Adsorbent for contrast agents
JP2534867B2 (en) Myoglobin adsorbent
JP2568846B2 (en) Myoglobin adsorbent
Chang Hemoperfusion in 1981
JPS6124019B2 (en)
JPS6139825B2 (en)
JPS58175565A (en) Serum treating apparatus
Nosé et al. Sorbents in therapeutic medicine
JPS6137963B2 (en)
WO2025084353A1 (en) Adsorbent, adsorption sheet, separation membrane, artificial dialysis equipment, and pharmaceutical composition